Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon lambda 3 | 0.506 | 0.808 | 2.4E-08 |
|
disease | 0.400 | None | 0.976 | 592 | 5 | 2009 | 2020 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.100 | None | 0.931 | 420 | 2 | 1984 | 2020 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.973 | 375 | 1 | 1994 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.973 | 374 | 3 | 1994 | 2019 | |||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
disease | 0.100 | None | 0.965 | 198 | 1 | 2000 | 2019 | ||||||||
|
vasoactive intestinal peptide receptor 1 | 0.573 | 0.654 | 7.4E-27 |
|
disease | 0.100 | None | 0.962 | 160 | 1 | 1992 | 2019 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.400 | None | 0.986 | 143 | 0 | 1992 | 2019 | |||||||||
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
disease | 0.100 | None | 1.000 | 118 | 0 | 1990 | 2019 | |||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.100 | None | 0.974 | 116 | 0 | 2007 | 2020 | |||||||||
|
CD81 molecule | 0.555 | 0.846 | 0.92 |
|
disease | 0.400 | None | 0.947 | 114 | 1 | 1998 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.960 | 101 | 2 | 1995 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.928 | 97 | 2 | 1996 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.100 | None | 0.910 | 89 | 4 | 1999 | 2019 | ||||||||
|
interferon lambda 4 (gene/pseudogene) | 0.670 | 0.577 |
|
disease | 0.200 | None | 0.952 | 83 | 6 | 2013 | 2020 | |||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.100 | None | 0.988 | 80 | 0 | 1995 | 2019 | ||||||||
|
BMP binding endothelial regulator | 0.641 | 0.577 | 6.6E-07 |
|
disease | 0.100 | None | 1.000 | 68 | 0 | 1992 | 2020 | ||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
disease | 0.100 | None | 1.000 | 64 | 0 | 1992 | 2019 | |||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
disease | 0.100 | None | 1.000 | 64 | 0 | 1992 | 2019 | |||||||||
|
Ras like without CAAX 2 | 0.647 | 0.538 | 6.3E-04 |
|
disease | 0.100 | None | 0.953 | 64 | 0 | 1991 | 2010 | ||||||||
|
ubiquitin conjugating enzyme E2 B | 0.644 | 0.615 | 0.20 |
|
disease | 0.100 | None | 1.000 | 63 | 0 | 1996 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.967 | 61 | 2 | 2001 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.951 | 61 | 3 | 1993 | 2018 | ||||||||
|
endogenous retrovirus group K member 32, envelope | 0.522 | 0.692 |
|
disease | 0.100 | None | 1.000 | 60 | 0 | 1990 | 2019 | |||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 0.981 | 54 | 1 | 1996 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
disease | 0.100 | None | 0.955 | 44 | 0 | 2000 | 2020 |